ICER

April 23, 2019

Issue Brief: Problems With The Institute of Clinical and Economic Review (ICER) and the QALY Methodology

This article by Chris Rochester appeared in The MacIver Institute on April 23, 2019. “What’s a year of life worth?” That compelling question was posed by Dr. William S. Smith, a visiting fellow at the Boston-based Pioneer Institute in a recent op-ed questioning...
April 23, 2019

Commentary: Proposed Drug Price Caps Would Stall Advances in Health Care

This op-ed by William Smith and Adam Crepeau appeared in the Portland Press Herald on April 23, 2019. Imagine if the Maine Legislature decided that large pickup trucks were becoming too expensive for the working class people who drive them.  Then imagine...
April 18, 2019

HHS Secretary Alex Azar doesn't want drug access to become an equation

This op-ed by William Smith appeared in the Washington Examiner on April 18, 2019. On April 8, at a Harvard Medical School forum hosted by Pioneer Institute, President Trump’s secretary of health and human services was asked whether it was advisable for...
February 22, 2019

The U.S. shouldn’t use the ‘QALY’ in drug cost-effectiveness reviews

This op-ed by William Smith appeared in STAT News on February 22, 2019. What’s a year of life worth? That question is at the heart of a metric called the quality-adjusted life year that is increasingly being used to make decisions about...
February 3, 2019

Baker’s Orwellian drug pricing policy

This op-ed by William Smith appeared in Commonwealth Magazine on February 3, 2019. THE BAKER ADMINISTRATION recently released its budget proposal for one of their most high-profile issues: drug prices in the Medicaid program. To the surprise of many in the biopharmaceutical industry, there are...
January 24, 2019

Study Urges Caution Before Adopting ICER Reviews to Determine Cost Effectiveness of Treatments

Review methodology could negatively impact elderly, the disabled, cancer patients and those with rare diseases Media inquiries: Contact Micaela Dawson, 617-723-2277 ext. 203 or mdawson@pioneerinstitute.org BOSTON – As states continue to grapple with prescription drug costs, a new Pioneer Institute study lays out...